Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study

Objectives We aimed to describe the gender-affirming hormonal therapy (GAHT) intake behaviour and regimen and the factors associated with the use of hormones inconsistent with reference GAHT regimen among transgender people in the Philippines.Design Cross-sectional study.Setting Transgender communit...

Full description

Bibliographic Details
Main Authors: Emmanuel S Baja, John Danvic T Rosadiño, Ronivin G Pagtakhan, Zypher Jude G Regencia, Patrick C Eustaquio, Jan Dio Miguel Dela Cruz, Yanyan Araña, Bubbles Rosos
Format: Article
Language:English
Published: BMJ Publishing Group 2023-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/9/e072252.full
_version_ 1797669411908222976
author Emmanuel S Baja
John Danvic T Rosadiño
Ronivin G Pagtakhan
Zypher Jude G Regencia
Patrick C Eustaquio
Jan Dio Miguel Dela Cruz
Yanyan Araña
Bubbles Rosos
author_facet Emmanuel S Baja
John Danvic T Rosadiño
Ronivin G Pagtakhan
Zypher Jude G Regencia
Patrick C Eustaquio
Jan Dio Miguel Dela Cruz
Yanyan Araña
Bubbles Rosos
author_sort Emmanuel S Baja
collection DOAJ
description Objectives We aimed to describe the gender-affirming hormonal therapy (GAHT) intake behaviour and regimen and the factors associated with the use of hormones inconsistent with reference GAHT regimen among transgender people in the Philippines.Design Cross-sectional study.Setting Transgender community clinic in Metro Manila, Philippines from March 2017 to December 2019.Participants Gender-affirming care-seeking individuals of at least 18 years old, who self-identified as transgender or non-binary, and who self-reported current or previous use of GAHT at baseline consult.Primary outcome measures Reported drugs and/or administration routes not congruent with the World Professional Association for Transgender Health Standard of Care eighth edition were classified as hormone use outside the reference regimen.Results 253 transgender people reported current or previous intake of GAHT. Many trans women and transfeminine people (TWTFP; 58.9%, 86/146) reported using oral contraceptive pills (OCPs), whereas most trans men (TM; 73.8%, 79/107) reported injecting testosterone esters. Furthermore, 59.7% (151/253) used hormones outside the reference regimen, widely using OCP and anabolic steroids among TWTFP and TM, respectively. TWTFP (crude prevalence ratio, PR, 3.52; 95% CI 2.35 to 5.49) and those who take unprescribed GAHT (crude PR 2.37; 95% CI 1.08 to 6.68) were more likely to use hormones outside the reference regimen than TM and taking healthcare provider-prescribed GAHT, respectively. On adjusting for covariates, the prevalence of using hormones outside the reference regimen was approximately three times higher (adjusted PR 3.22; 95% CI 2.09 to 5.12) among TWTFP than TM.Conclusion Trans people act on their high unmet gender-affirming care needs by taking unprescribed GAHT, many outside the reference regimen. Structural changes in the health system are warranted, including strengthened community-based self-administration practices.
first_indexed 2024-03-11T20:43:59Z
format Article
id doaj.art-f79cbacf3c004290a9a9fcbae6012dfc
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-03-11T20:43:59Z
publishDate 2023-09-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-f79cbacf3c004290a9a9fcbae6012dfc2023-10-01T21:05:08ZengBMJ Publishing GroupBMJ Open2044-60552023-09-0113910.1136/bmjopen-2023-072252Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional studyEmmanuel S Baja0John Danvic T Rosadiño1Ronivin G Pagtakhan2Zypher Jude G Regencia3Patrick C Eustaquio4Jan Dio Miguel Dela Cruz5Yanyan Araña6Bubbles Rosos7Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines Manila, Manila, PhilippinesLoveYourself Inc, Mandaluyong City, PhilippinesLoveYourself Inc, Mandaluyong City, PhilippinesInstitute of Clinical Epidemiology, National Institutes of Health, University of the Philippines Manila, Manila, PhilippinesLoveYourself Inc, Mandaluyong City, PhilippinesLoveYourself Inc, Mandaluyong City, PhilippinesLoveYourself Inc, Mandaluyong City, PhilippinesLoveYourself Inc, Mandaluyong City, PhilippinesObjectives We aimed to describe the gender-affirming hormonal therapy (GAHT) intake behaviour and regimen and the factors associated with the use of hormones inconsistent with reference GAHT regimen among transgender people in the Philippines.Design Cross-sectional study.Setting Transgender community clinic in Metro Manila, Philippines from March 2017 to December 2019.Participants Gender-affirming care-seeking individuals of at least 18 years old, who self-identified as transgender or non-binary, and who self-reported current or previous use of GAHT at baseline consult.Primary outcome measures Reported drugs and/or administration routes not congruent with the World Professional Association for Transgender Health Standard of Care eighth edition were classified as hormone use outside the reference regimen.Results 253 transgender people reported current or previous intake of GAHT. Many trans women and transfeminine people (TWTFP; 58.9%, 86/146) reported using oral contraceptive pills (OCPs), whereas most trans men (TM; 73.8%, 79/107) reported injecting testosterone esters. Furthermore, 59.7% (151/253) used hormones outside the reference regimen, widely using OCP and anabolic steroids among TWTFP and TM, respectively. TWTFP (crude prevalence ratio, PR, 3.52; 95% CI 2.35 to 5.49) and those who take unprescribed GAHT (crude PR 2.37; 95% CI 1.08 to 6.68) were more likely to use hormones outside the reference regimen than TM and taking healthcare provider-prescribed GAHT, respectively. On adjusting for covariates, the prevalence of using hormones outside the reference regimen was approximately three times higher (adjusted PR 3.22; 95% CI 2.09 to 5.12) among TWTFP than TM.Conclusion Trans people act on their high unmet gender-affirming care needs by taking unprescribed GAHT, many outside the reference regimen. Structural changes in the health system are warranted, including strengthened community-based self-administration practices.https://bmjopen.bmj.com/content/13/9/e072252.full
spellingShingle Emmanuel S Baja
John Danvic T Rosadiño
Ronivin G Pagtakhan
Zypher Jude G Regencia
Patrick C Eustaquio
Jan Dio Miguel Dela Cruz
Yanyan Araña
Bubbles Rosos
Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study
BMJ Open
title Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study
title_full Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study
title_fullStr Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study
title_full_unstemmed Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study
title_short Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study
title_sort prevalence of and factors associated with the use of gender affirming hormonal therapy outside the reference regimen among transgender people in a community led clinic in metro manila philippines a retrospective cross sectional study
url https://bmjopen.bmj.com/content/13/9/e072252.full
work_keys_str_mv AT emmanuelsbaja prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy
AT johndanvictrosadino prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy
AT ronivingpagtakhan prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy
AT zypherjudegregencia prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy
AT patrickceustaquio prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy
AT jandiomigueldelacruz prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy
AT yanyanarana prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy
AT bubblesrosos prevalenceofandfactorsassociatedwiththeuseofgenderaffirminghormonaltherapyoutsidethereferenceregimenamongtransgenderpeopleinacommunityledclinicinmetromanilaphilippinesaretrospectivecrosssectionalstudy